SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NORTH AMERICAN VACCINE (NVX)
NVX 1.510-3.8%Oct 31 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don W Stone who wrote ()2/10/1997 11:56:00 AM
From: andy harrison   of 21
 
Don:
The thrust of the Individual Investor article about NVX was
that they would be under financial duress in 1997. A fair reading
of the facts using their information would be as follows:
Expenditure:
$36 million per rate per year($9 million/quarter) plus $5 Million
interest payment for Convertable Bonds Outstanding - $5 million.

TOTAL EXPENDITURES -1997 $41 million

TOTAL REVENUES:
(All of this is information that is public knowledge).

Abbott Labs who is NVX's marketing partner owes a balance of $29
million to NVX upon FDA approval of DTaP. The article says
that NVX will receive approval no later than 4th. quarter of 1997.
(I feel that it will be sooner).

NVX has a deal with Rhone Polence(Sp?) for NVX's next generation
Menigitis B vaccine for which NVX is receiving yearly milestone
payments of $10 million per year.

The article says that revenues were $3.7 million.

That totals up to $42.7 million which means that NVX has a potential
positive cash flow of $1.7 million. With approximately $80 million
in the bank (some of it earning interest) and upfront payments and
royalties from Chiron Behring for sales in Germany and Austria; NVX
should become solidly in the black on a cash flow basis for 1997.
1998 the company should be selling product in several countries including
the Good ole" US of A. I think that the article should have come
to the conclusion that the shorts are in a tougher predicament than
the longs.

Regards,

Andy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News